 | • レポートコード：MRC2-11QY11181 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は脳疾患のグローバル市場について調査・分析したレポートです。種類別（脳腫瘍、アルツハイマー病、アルコール依存症、健忘症、癲癇、髄膜炎、その他）市場規模、用途別（病院薬局、オンライン薬局、薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別脳疾患の競争状況、市場シェア ・世界の脳疾患市場：種類別市場規模 2015年-2020年（脳腫瘍、アルツハイマー病、アルコール依存症、健忘症、癲癇、髄膜炎、その他） ・世界の脳疾患市場：種類別市場規模予測 2021年-2026年（脳腫瘍、アルツハイマー病、アルコール依存症、健忘症、癲癇、髄膜炎、その他） ・世界の脳疾患市場：用途別市場規模 2015年-2020年（病院薬局、オンライン薬局、薬局） ・世界の脳疾患市場：用途別市場規模予測 2021年-2026年（病院薬局、オンライン薬局、薬局） ・北米の脳疾患市場分析：米国、カナダ ・ヨーロッパの脳疾患市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの脳疾患市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の脳疾患市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの脳疾患市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Pfizer、Eli Lilly、F. Hoffmann La Roche、GE Healthcare、Janssen Pharmaceuticals、Abbvie、AC Immune、Allergan、Merck、Novartis、AstraZeneca ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Brain diseases a part of central nervous system diseases, is a condition where the brain structure or functions alter. The brain diseases include conditions or disabilities that affect the brain. Mostly brain disorders occur due to traumatic injury, genetic or other diseases, while a small number of brain diseases occur due to environmental factors. The major concerned brain disease are caused due to brain deterioration which may lead to neurodegenerative diseases such as Alzheimer’s, Huntington’s disease, and others. The mental disorders or mental illness occurrence is also related to the brain diseases, which include depression, anxiety, bipolar disorders, and others. The etiology of brain disease is not specific. It can occur to anyone and the risk factors of brain diseases differ in accordance to the different types of brain diseases. The sign and symptoms also differ for every brain diseases. Some of the most common symptoms include headache, memory loss, tremors, increased reflexes, slurred speech, paralysis, and inability to concentrate among others. Moreover, the treatment of brain diseases range from surgery to rehabilitation to medications; depending upon the brain disease the patient is affected by. The brain diseases are progressive which may affect the daily life of patients and hence should be immediately treated upon their diagnosis or detection.
The incidence and prevalence of brain diseases and disorders increase with age. The growing baby booming population is the major factor driving the brain disease market, globally. Rising prevalence of brain diseases is expected to boost the growth of the market. Due lack of effective treatment for some brain diseases such as brain cancer, they are a huge demand for medicinal treatment. Because of this reason, key market players are intensively focusing on R&D to develop a safe and effective treatment for brain diseases. All these factors act as driver for burgeoning growth of the brain disease market. However, adverse effects associated with the medications of brain diseases is anticipated to hinder the market growth.
Market Analysis and Insights: Global Brain Disease Market
The global Brain Disease market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Brain Disease Scope and Market Size
Brain Disease market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Brain Disease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Pfizer
Eli Lilly
F. Hoffmann La Roche
GE Healthcare
Janssen Pharmaceuticals
Abbvie
AC Immune
Allergan
Merck
Novartis
AstraZeneca
Market segment by Type, the product can be split into
Brain Cancer
Alzheimer Disease
Alcoholism
Amnesia
Epilepsy
Meningitis
Others
Market segment by Application, split into
Hospitals Pharmacy
Online Pharmacy
Pharmacy
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Brain Disease Revenue
1.4 Market by Type
1.4.1 Global Brain Disease Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Brain Cancer
1.4.3 Alzheimer Disease
1.4.4 Alcoholism
1.4.5 Amnesia
1.4.6 Epilepsy
1.4.7 Meningitis
1.4.8 Others
1.5 Market by Application
1.5.1 Global Brain Disease Market Share by Application: 2020 VS 2026
1.5.2 Hospitals Pharmacy
1.5.3 Online Pharmacy
1.5.4 Pharmacy
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Brain Disease Market Perspective (2015-2026)
2.2 Global Brain Disease Growth Trends by Regions
2.2.1 Brain Disease Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Brain Disease Historic Market Share by Regions (2015-2020)
2.2.3 Brain Disease Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Brain Disease Market Growth Strategy
2.3.6 Primary Interviews with Key Brain Disease Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Brain Disease Players by Market Size
3.1.1 Global Top Brain Disease Players by Revenue (2015-2020)
3.1.2 Global Brain Disease Revenue Market Share by Players (2015-2020)
3.1.3 Global Brain Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Brain Disease Market Concentration Ratio
3.2.1 Global Brain Disease Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Brain Disease Revenue in 2019
3.3 Brain Disease Key Players Head office and Area Served
3.4 Key Players Brain Disease Product Solution and Service
3.5 Date of Enter into Brain Disease Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Brain Disease Historic Market Size by Type (2015-2020)
4.2 Global Brain Disease Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Brain Disease Market Size by Application (2015-2020)
5.2 Global Brain Disease Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Brain Disease Market Size (2015-2020)
6.2 Brain Disease Key Players in North America (2019-2020)
6.3 North America Brain Disease Market Size by Type (2015-2020)
6.4 North America Brain Disease Market Size by Application (2015-2020)
7 Europe
7.1 Europe Brain Disease Market Size (2015-2020)
7.2 Brain Disease Key Players in Europe (2019-2020)
7.3 Europe Brain Disease Market Size by Type (2015-2020)
7.4 Europe Brain Disease Market Size by Application (2015-2020)
8 China
8.1 China Brain Disease Market Size (2015-2020)
8.2 Brain Disease Key Players in China (2019-2020)
8.3 China Brain Disease Market Size by Type (2015-2020)
8.4 China Brain Disease Market Size by Application (2015-2020)
9 Japan
9.1 Japan Brain Disease Market Size (2015-2020)
9.2 Brain Disease Key Players in Japan (2019-2020)
9.3 Japan Brain Disease Market Size by Type (2015-2020)
9.4 Japan Brain Disease Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Brain Disease Market Size (2015-2020)
10.2 Brain Disease Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Brain Disease Market Size by Type (2015-2020)
10.4 Southeast Asia Brain Disease Market Size by Application (2015-2020)
11 India
11.1 India Brain Disease Market Size (2015-2020)
11.2 Brain Disease Key Players in India (2019-2020)
11.3 India Brain Disease Market Size by Type (2015-2020)
11.4 India Brain Disease Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Brain Disease Market Size (2015-2020)
12.2 Brain Disease Key Players in Central & South America (2019-2020)
12.3 Central & South America Brain Disease Market Size by Type (2015-2020)
12.4 Central & South America Brain Disease Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Pfizer
13.1.1 Pfizer Company Details
13.1.2 Pfizer Business Overview
13.1.3 Pfizer Brain Disease Introduction
13.1.4 Pfizer Revenue in Brain Disease Business (2015-2020))
13.1.5 Pfizer Recent Development
13.2 Eli Lilly
13.2.1 Eli Lilly Company Details
13.2.2 Eli Lilly Business Overview
13.2.3 Eli Lilly Brain Disease Introduction
13.2.4 Eli Lilly Revenue in Brain Disease Business (2015-2020)
13.2.5 Eli Lilly Recent Development
13.3 F. Hoffmann La Roche
13.3.1 F. Hoffmann La Roche Company Details
13.3.2 F. Hoffmann La Roche Business Overview
13.3.3 F. Hoffmann La Roche Brain Disease Introduction
13.3.4 F. Hoffmann La Roche Revenue in Brain Disease Business (2015-2020)
13.3.5 F. Hoffmann La Roche Recent Development
13.4 GE Healthcare
13.4.1 GE Healthcare Company Details
13.4.2 GE Healthcare Business Overview
13.4.3 GE Healthcare Brain Disease Introduction
13.4.4 GE Healthcare Revenue in Brain Disease Business (2015-2020)
13.4.5 GE Healthcare Recent Development
13.5 Janssen Pharmaceuticals
13.5.1 Janssen Pharmaceuticals Company Details
13.5.2 Janssen Pharmaceuticals Business Overview
13.5.3 Janssen Pharmaceuticals Brain Disease Introduction
13.5.4 Janssen Pharmaceuticals Revenue in Brain Disease Business (2015-2020)
13.5.5 Janssen Pharmaceuticals Recent Development
13.6 Abbvie
13.6.1 Abbvie Company Details
13.6.2 Abbvie Business Overview
13.6.3 Abbvie Brain Disease Introduction
13.6.4 Abbvie Revenue in Brain Disease Business (2015-2020)
13.6.5 Abbvie Recent Development
13.7 AC Immune
13.7.1 AC Immune Company Details
13.7.2 AC Immune Business Overview
13.7.3 AC Immune Brain Disease Introduction
13.7.4 AC Immune Revenue in Brain Disease Business (2015-2020)
13.7.5 AC Immune Recent Development
13.8 Allergan
13.8.1 Allergan Company Details
13.8.2 Allergan Business Overview
13.8.3 Allergan Brain Disease Introduction
13.8.4 Allergan Revenue in Brain Disease Business (2015-2020)
13.8.5 Allergan Recent Development
13.9 Merck
13.9.1 Merck Company Details
13.9.2 Merck Business Overview
13.9.3 Merck Brain Disease Introduction
13.9.4 Merck Revenue in Brain Disease Business (2015-2020)
13.9.5 Merck Recent Development
13.10 Novartis
13.10.1 Novartis Company Details
13.10.2 Novartis Business Overview
13.10.3 Novartis Brain Disease Introduction
13.10.4 Novartis Revenue in Brain Disease Business (2015-2020)
13.10.5 Novartis Recent Development
13.11 AstraZeneca
10.11.1 AstraZeneca Company Details
10.11.2 AstraZeneca Business Overview
10.11.3 AstraZeneca Brain Disease Introduction
10.11.4 AstraZeneca Revenue in Brain Disease Business (2015-2020)
10.11.5 AstraZeneca Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Brain Disease Key Market Segments
Table 2. Key Players Covered: Ranking by Brain Disease Revenue
Table 3. Ranking of Global Top Brain Disease Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Brain Disease Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Brain Cancer
Table 6. Key Players of Alzheimer Disease
Table 7. Key Players of Alcoholism
Table 8. Key Players of Amnesia
Table 9. Key Players of Epilepsy
Table 10. Key Players of Meningitis
Table 11. Key Players of Others
Table 12. Global Brain Disease Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Brain Disease Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Brain Disease Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Brain Disease Market Share by Regions (2015-2020)
Table 16. Global Brain Disease Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Brain Disease Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Brain Disease Market Growth Strategy
Table 22. Main Points Interviewed from Key Brain Disease Players
Table 23. Global Brain Disease Revenue by Players (2015-2020) (Million US$)
Table 24. Global Brain Disease Market Share by Players (2015-2020)
Table 25. Global Top Brain Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Brain Disease as of 2019)
Table 26. Global Brain Disease by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Brain Disease Product Solution and Service
Table 29. Date of Enter into Brain Disease Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Brain Disease Market Size by Type (2015-2020) (Million US$)
Table 32. Global Brain Disease Market Size Share by Type (2015-2020)
Table 33. Global Brain Disease Revenue Market Share by Type (2021-2026)
Table 34. Global Brain Disease Market Size Share by Application (2015-2020)
Table 35. Global Brain Disease Market Size by Application (2015-2020) (Million US$)
Table 36. Global Brain Disease Market Size Share by Application (2021-2026)
Table 37. North America Key Players Brain Disease Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Brain Disease Market Share (2019-2020)
Table 39. North America Brain Disease Market Size by Type (2015-2020) (Million US$)
Table 40. North America Brain Disease Market Share by Type (2015-2020)
Table 41. North America Brain Disease Market Size by Application (2015-2020) (Million US$)
Table 42. North America Brain Disease Market Share by Application (2015-2020)
Table 43. Europe Key Players Brain Disease Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Brain Disease Market Share (2019-2020)
Table 45. Europe Brain Disease Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Brain Disease Market Share by Type (2015-2020)
Table 47. Europe Brain Disease Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Brain Disease Market Share by Application (2015-2020)
Table 49. China Key Players Brain Disease Revenue (2019-2020) (Million US$)
Table 50. China Key Players Brain Disease Market Share (2019-2020)
Table 51. China Brain Disease Market Size by Type (2015-2020) (Million US$)
Table 52. China Brain Disease Market Share by Type (2015-2020)
Table 53. China Brain Disease Market Size by Application (2015-2020) (Million US$)
Table 54. China Brain Disease Market Share by Application (2015-2020)
Table 55. Japan Key Players Brain Disease Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Brain Disease Market Share (2019-2020)
Table 57. Japan Brain Disease Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Brain Disease Market Share by Type (2015-2020)
Table 59. Japan Brain Disease Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Brain Disease Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Brain Disease Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Brain Disease Market Share (2019-2020)
Table 63. Southeast Asia Brain Disease Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Brain Disease Market Share by Type (2015-2020)
Table 65. Southeast Asia Brain Disease Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Brain Disease Market Share by Application (2015-2020)
Table 67. India Key Players Brain Disease Revenue (2019-2020) (Million US$)
Table 68. India Key Players Brain Disease Market Share (2019-2020)
Table 69. India Brain Disease Market Size by Type (2015-2020) (Million US$)
Table 70. India Brain Disease Market Share by Type (2015-2020)
Table 71. India Brain Disease Market Size by Application (2015-2020) (Million US$)
Table 72. India Brain Disease Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Brain Disease Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Brain Disease Market Share (2019-2020)
Table 75. Central & South America Brain Disease Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Brain Disease Market Share by Type (2015-2020)
Table 77. Central & South America Brain Disease Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Brain Disease Market Share by Application (2015-2020)
Table 79. Pfizer Company Details
Table 80. Pfizer Business Overview
Table 81. Pfizer Product
Table 82. Pfizer Revenue in Brain Disease Business (2015-2020) (Million US$)
Table 83. Pfizer Recent Development
Table 84. Eli Lilly Company Details
Table 85. Eli Lilly Business Overview
Table 86. Eli Lilly Product
Table 87. Eli Lilly Revenue in Brain Disease Business (2015-2020) (Million US$)
Table 88. Eli Lilly Recent Development
Table 89. F. Hoffmann La Roche Company Details
Table 90. F. Hoffmann La Roche Business Overview
Table 91. F. Hoffmann La Roche Product
Table 92. F. Hoffmann La Roche Revenue in Brain Disease Business (2015-2020) (Million US$)
Table 93. F. Hoffmann La Roche Recent Development
Table 94. GE Healthcare Company Details
Table 95. GE Healthcare Business Overview
Table 96. GE Healthcare Product
Table 97. GE Healthcare Revenue in Brain Disease Business (2015-2020) (Million US$)
Table 98. GE Healthcare Recent Development
Table 99. Janssen Pharmaceuticals Company Details
Table 100. Janssen Pharmaceuticals Business Overview
Table 101. Janssen Pharmaceuticals Product
Table 102. Janssen Pharmaceuticals Revenue in Brain Disease Business (2015-2020) (Million US$)
Table 103. Janssen Pharmaceuticals Recent Development
Table 104. Abbvie Company Details
Table 105. Abbvie Business Overview
Table 106. Abbvie Product
Table 107. Abbvie Revenue in Brain Disease Business (2015-2020) (Million US$)
Table 108. Abbvie Recent Development
Table 109. AC Immune Company Details
Table 110. AC Immune Business Overview
Table 111. AC Immune Product
Table 112. AC Immune Revenue in Brain Disease Business (2015-2020) (Million US$)
Table 113. AC Immune Recent Development
Table 114. Allergan Business Overview
Table 115. Allergan Product
Table 116. Allergan Company Details
Table 117. Allergan Revenue in Brain Disease Business (2015-2020) (Million US$)
Table 118. Allergan Recent Development
Table 119. Merck Company Details
Table 120. Merck Business Overview
Table 121. Merck Product
Table 122. Merck Revenue in Brain Disease Business (2015-2020) (Million US$)
Table 123. Merck Recent Development
Table 124. Novartis Company Details
Table 125. Novartis Business Overview
Table 126. Novartis Product
Table 127. Novartis Revenue in Brain Disease Business (2015-2020) (Million US$)
Table 128. Novartis Recent Development
Table 129. AstraZeneca Company Details
Table 130. AstraZeneca Business Overview
Table 131. AstraZeneca Product
Table 132. AstraZeneca Revenue in Brain Disease Business (2015-2020) (Million US$)
Table 133. AstraZeneca Recent Development
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Brain Disease Market Share by Type: 2020 VS 2026
Figure 2. Brain Cancer Features
Figure 3. Alzheimer Disease Features
Figure 4. Alcoholism Features
Figure 5. Amnesia Features
Figure 6. Epilepsy Features
Figure 7. Meningitis Features
Figure 8. Others Features
Figure 9. Global Brain Disease Market Share by Application: 2020 VS 2026
Figure 10. Hospitals Pharmacy Case Studies
Figure 11. Online Pharmacy Case Studies
Figure 12. Pharmacy Case Studies
Figure 13. Brain Disease Report Years Considered
Figure 14. Global Brain Disease Market Size YoY Growth 2015-2026 (US$ Million)
Figure 15. Global Brain Disease Market Share by Regions: 2020 VS 2026
Figure 16. Global Brain Disease Market Share by Regions (2021-2026)
Figure 17. Porter's Five Forces Analysis
Figure 18. Global Brain Disease Market Share by Players in 2019
Figure 19. Global Top Brain Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Brain Disease as of 2019
Figure 20. The Top 10 and 5 Players Market Share by Brain Disease Revenue in 2019
Figure 21. North America Brain Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Europe Brain Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. China Brain Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Japan Brain Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Southeast Asia Brain Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. India Brain Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Central & South America Brain Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Bottom-up and Top-down Approaches for This Report
Figure 29. Data Triangulation
Figure 30. Key Executives Interviewed
脳深部刺激療法（DBS）の世界市場（～2026年） Deep brain stimulation (DBS) is a neurosurgical procedure involving the implantation of a medical device called a neurostimulator (sometimes referred to as a 'brain pacemaker'), which sends electrical impulses, through implanted electrodes, to specific targets in the brain (brain nuclei) for the tre…- 外傷性脳損傷治療の世界市場（～2026年） Traumatic brain injury usually results from a violent blow or jolt to the head or body. Market Analysis and Insights: Global Traumatic Brain Injuries Treatment Market The global Traumatic Brain Injuries Treatment market size is projected to reach US$ 2178.1 million by 2026, from US$ 2112.1 million i…
- 小児脳腫瘍の世界市場（～2026年） Pediatric brain tumors are masses or growths of abnormal cells that occur in a child's brain or the tissue and structures that are near it. Many different types of pediatric brain tumors exist — some are noncancerous (benign) and some are cancerous (malignant). Treatment and chance of recovery (prog…
- 脳腫瘍治療薬の世界市場（～2026年） A brain tumor occurs when abnormal cells form within the brain. North America dominates the brain tumor therapeutics market due to increasing technological advancements and the rising incidences of brain cancer in the country. Asia-Pacific is also expected to propel the brain tumor therapeutics mark…
- アルツハイマー病の世界市場（～2026年） Market Analysis and Insights: Global Alzheimer's Disease Market The global Alzheimer's Disease market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Alzheimer's Disease Scope and Market Size Alzheimer's Disease market is seg…